Juvenile Idiopathic Arthritis News and Research

RSS

Juvenile idiopathic arthritis (JIA) is the name given to a group of conditions characterized by joint inflammation or arthritis, occurring first before the age of 16.

Linking perinatal events to juvenile idiopathic arthritis-uveitis

Researchers investigate perinatal events associated with the manifestation of juvenile idiopathic arthritis and the development of JIA-uveitis.

20 Oct 2023

Comparative genomic analysis between systemic juvenile rheumatoid arthritis and type 1 diabetes

Shared genetic markers and immune system involvement in sJRA and T1D.

15 Sep 2023

Study discovers method to classify febrile illness with a single blood sample

Researchers trained machine learning (ML) models to analyze RNA molecular signatures in patients’ blood.

28 Aug 2023

Arthritis affects 220,000 children and teens, according to a new CDC study

In a recent MMWR published by the United States CDC, researchers combine survey data from the NSCH collected over a five-year period to estimate the prevalence of arthritis.

26 Jul 2023

PCORI awards $208 million to fund 17 new comparative clinical effectiveness research studies

The Patient-Centered Outcomes Research Institute (PCORI) today announced funding awards totaling $208 million to support 17 new comparative clinical effectiveness research (CER) studies, including four trials of particularly large scale and scope tackling complex questions.

18 Jul 2023

Early life gut flora may play a role in juvenile idiopathic arthritis

More than ten years before being diagnosed with child rheumatism, children who developed the disease had a gut flora differing in several ways from that of children who remained healthy.

5 Jul 2023

Interdisciplinary guidelines for treatment of children with arthritis of the jaw

Interdisciplinary guidelines to optimize the treatment of childhood arthritis at global level. So far, there no uniform guidelines have existed for the treatment of arthritis of the jaw, a potentially debilitating consequence of juvenile arthritis.

20 Nov 2022

One Medicine: how human and veterinary medicine can benefit each other

News-Medical speaks to Professor Roberto La Ragione, Chair of Trustees at Humanimal Trust, about the concept of One Medicine and how human and veterinary medicine can collaborate, share knowledge, and initiate research for the benefit of both humans and animals.

26 Oct 2022

EULAR points-to-consider offers support to improve healthy work participation of people with RMDs

Across Europe, people with RMDs are less able to work than people in the general population. One of the most common reasons is that people with RMDs often have pain caused by their disease.

20 Oct 2022

Study finds higher risk of premature death among patients with pediatric onset immune-mediated inflammatory disease

Patients with a pediatric onset immune-mediated inflammatory disease have a significantly higher risk of premature death, according to new research being presented today at the 54th Annual Meeting of the European Society for Paediatric Gastroenterology, Hepatology and Nutrition.

26 Jun 2022

Updated guideline released for managing antirheumatic drugs in patients undergoing hip or knee replacement

The American College of Rheumatology and the American Association of Hip and Knee Surgeons released a summary of their updated guideline for the Perioperative Management of Antirheumatic Medication in Patients with Rheumatic Diseases Undergoing Elective Total Hip or Total Knee Arthroplasty.

28 Feb 2022

Early combination treatment achieves clinically inactive disease in children with polyarticular JIA

New research presented this week at ACR Convergence, the American College of Rheumatology's annual meeting, found that patients started on early, aggressive treatment with a combination of biologic and conventional disease modifying antirheumatic drugs (DMARDs) achieved clinically inactive disease in children with polyarticular juvenile idiopathic arthritis (JIA) more frequently compared to other treatment plans 24 months after starting treatment.

2 Nov 2021

Effect of biologic therapy on COVID-19 in children suffering from rheumatic diseases

A new study aimed to determine the course of SARS-CoV-2 infection in children suffering from rheumatic disease and were receiving bDMARD treatment.

29 Sep 2021

Maternal and paternal inflammatory disease can affect pregnancy outcomes

Data presented at the 2021 EULAR congress show women with rheumatoid arthritis (RA) are at increased risks of adverse pregnancy outcomes, especially pre-term birth and babies small for gestational age.

18 Jun 2021

Study explores COVID-19 outcomes in people with RA

Arani Vivekanantham and colleagues investigated the association between RA and the risk of COVID-19 diagnosis, hospitalization with COVID-19,and COVID-19-related death.

18 Jun 2021

What is the role of monoclonal antibody therapy in treating COVID-19?

A new study has been published in the journal Vaccines that deals with the present state of research on using mAbs for the treatment of the COVID-19 disease. Many clinical trials are being conducted to evaluate the efficacy and safety of several newly designed mAbs. Some of the mAbs are directed towards immune system responses, i.e., non-SARS-CoV-2 specific mAbs, while others are devised to neutralize the SARS-CoV-2 protein structure, i.e., SARS-CoV-2 specific mAbs.

8 Jun 2021

Juvenile Idiopathic Arthritis News and Research

Further Reading

Linking perinatal events to juvenile idiopathic arthritis-uveitis

Comparative genomic analysis between systemic juvenile rheumatoid arthritis and type 1 diabetes

Study discovers method to classify febrile illness with a single blood sample

Arthritis affects 220,000 children and teens, according to a new CDC study

PCORI awards $208 million to fund 17 new comparative clinical effectiveness research studies

Early life gut flora may play a role in juvenile idiopathic arthritis

Interdisciplinary guidelines for treatment of children with arthritis of the jaw

One Medicine: how human and veterinary medicine can benefit each other

EULAR points-to-consider offers support to improve healthy work participation of people with RMDs

Study finds higher risk of premature death among patients with pediatric onset immune-mediated inflammatory disease

Updated guideline released for managing antirheumatic drugs in patients undergoing hip or knee replacement

Early combination treatment achieves clinically inactive disease in children with polyarticular JIA

Effect of biologic therapy on COVID-19 in children suffering from rheumatic diseases

Maternal and paternal inflammatory disease can affect pregnancy outcomes

Study explores COVID-19 outcomes in people with RA

What is the role of monoclonal antibody therapy in treating COVID-19?

International coalition develops classification criteria for 25 subtypes of uveitis

Study: Repurposed arthritis drug did not improve outcomes of patients with severe COVID-19 pneumonia

Juvenile inflammatory rheumatic disease associated with higher antibody responses to seasonal coronaviruses

HSS presents research related to rheumatology and orthopedic surgery at 2020 ACR annual meeting

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News